Armistice Capital »

Nautilus shares owned by Armistice Capital

Quarter-by-quarter ownership of Nautilus (BFXXQ) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nautilus

Tip: Access up to 7 years of quarterly data

All positions including Nautilus held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.9M 2.3M 0.85
2023-06-30 $4.0M 3.3M 1.22

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Nautilus

Vanguard Group
Two Sigma Advisers
Citadel Advisors
Squarepoint Ops
T. Rowe Price Associates
Two Sigma Investments
SG Americas Securities
Waterfront Wealth
Millennium Management
Mariner Wealth Advisors
UBS Group
Mraz, Amerine & Associates
Focused Wealth Management
Jpmorgan Chase & Co
Partnership Wealth Management

View all funds holding Nautilus